Skip to content

comparison between 3 steroid injections for treating heel pain

comparative study of local injections of Methyl prednisolone, triamcinolone and dexamethasone in management of plantar fascitis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011764
Enrollment
60
Registered
2018-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Plantar fascitis

Interventions

Intervention1: injection methyl prednisolone: injection methyl prednisolone which is a glucocorticoid will be given stat locally in the heel to patients of group A Control Intervention1: Injection tri

Sponsors

no
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to participate in the study and give consent. 2.Age group of 18-65 years of either sex. 3.Diagnosed cases of plantar fasciitis having symptoms for > 6 weeks. 4.Patients who had a fair trial of other conservative treatment but got no relief. 5.Patients who have not taken the study injectables previously.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Patients who are immunocompromised. 3.Patients with history of diabetes, hypertension and tuberculosis. 4.Patient having history of infection in last 3 months 5.Patients with history of psychiatric disorders. 6.Patient with history of peptic ulcer 7.Patients with history of osteoporosis. 8.Patients with history of trauma to heel.

Design outcomes

Primary

MeasureTime frame
reduction in painTimepoint: At the end of 2 and 4 weeks

Secondary

MeasureTime frame
reduction in discomfortTimepoint: At the end of 2 and 4 weeks

Countries

India

Contacts

Public ContactDr shaikh Huzaif Badiuddin

MGMs medical college, Aurangabad

huzaifshaikh001@gmail.com9156495919

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026